| Autor: |
Lathrop JT; Plasma Derivatives Department, Holland Laboratory for the Biomedical Sciences, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA. lathropj@usa.redcross.org, Anderson NL, Anderson NG, Hammond DJ |
| Jazyk: |
angličtina |
| Zdroj: |
Current opinion in molecular therapeutics [Curr Opin Mol Ther] 2003 Jun; Vol. 5 (3), pp. 250-7. |
| Abstrakt: |
Plasma contains numerous and diverse proteins with existing and potential therapeutic value. Plasma has been used clinically as both a source of purified derivatives for treating diseases such as hemophilia, and as a diagnostic medium. Recent research directed towards mining plasma's true potential takes advantage of state-of-the-art proteomic analytical methods to develop multi-protein, disease-specific biomarker panels to improve the reliability and specificity of diagnostics. Recombinant production and chromatographic purification methods are increasing the yield and safety of traditional plasma derivatives. Emerging cell-based technologies are being applied to discover novel protein activities and identify epitope-specific antibodies that may have clinical promise. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
